|本期目录/Table of Contents|

[1]杨晋翔,来要良.酒精性肝纤维化中医证候研究评述[J].环球中医药,2012,5(04):310-0.
　YANG Jin xiang,LAI Yao liang..Review of TCM syndromes of alcoholic liver fibrosis[J].,2012,5(04):310-0.
点击复制

酒精性肝纤维化中医证候研究评述()
     
分享到：

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第5卷
期数:
2012年04期
页码:
310-0
栏目:
综述
出版日期:
2012-04-06

文章信息/Info

Title:
Review of TCM syndromes of alcoholic liver fibrosis
作者:
杨晋翔; 来要良;
Author(s):
YANG Jinxiang;  LAI Yaoliang.
The Third Hospital Affiliated to Beijing University of Chinese Medicine, Beijing　100029, China
关键词:
酒精性肝纤维化;  中医证候;  述评
Keywords:
Alcoholic liver fibrosis; Syndrome of TCM; Review
分类号:
R657.3
DOI:
-
文献标志码:
A
摘要:
酒精性肝纤维化是目前研究的热点,中医治疗存在一定的优势。中医虽然对酒精性肝纤维化病名、病机及治疗进行了研究,但是至今仍然不够深入。本文从酒精性肝纤维化证候的文献回顾、证素研究、临床证候分布、实验室指标方面对证候研究现状进行了评述。认为对酒精性肝纤维化的病机和症状特点认识不同,造成证型判定不同或者证候命名不同,主要证型间的程度分级以及证候减轻、缓解或演变与病变的关系不明确,没有与病相结合形成合理的证型。酒精性肝纤维化证候研究已取得了较大的进展,但仍存在一些值得深入研讨的问题。
Abstract:
The study of alcoholic liver fibrosis is a hot topic at present and TCM has some advantage in treatment. Although TCM has done some deep research on alcoholic liver from the aspects of syndrome, pathogenesis and treatment, but it is still not profound enough. From literature review, syndrome element, laboratory index and frequency, we make a review on TCM syndromes of alcoholic liver fibrosis. Different understanding of pathogenesis and symptoms caused differently named syndrome and main syndrome. The relationship between loss, remission or evolution of syndrome and disease is not clear. There is no reasonable syndrome combined to disease. Great progress has been made in research of alcoholic hepatic fibrosis syndrome, but there are still some issues worthy of discussion.

参考文献/References:

[1]中国中西医结合学会肝病专业委员会.肝纤维化中西医结合诊疗指南［J］.中西医结合肝病杂志,2006,16(5):316320.
[2］中华全国中医学会内科肝病专业委员会.病毒性肝炎中医辨证标准（试行）［J］.中医杂志,1992,33(5):39.
[3］中国中西医结合学会消化系统疾病专业委员会.肝硬化中西医结合诊治方案（草案）［J］.中国中西医结合杂志,2004,24(10):869871.
[4］林宗广.怎样辨治酒精性肝病［J］.中医杂志,1997,38(8):502.
[5］张明雪.酒精性肝病的中医证治与微观化研究［J］.辽宁中医杂志,1996,23(7):299300.
[6］崔闽鲁.清肝解酒饮治疗酒精性肝病临床研究［J］.中医杂志,1998,39(1):3233.
[7］季光,王育群.清肝活血汤治疗酒精性肝病疗效观察［J］.辽宁中医杂志,1999,26(5):209210.
[8］李丰衣,孙劲晖,田德禄.田德禄教授治疗酒精性肝纤维化经验浅探［J］.古林中医药,2006,26(8):1011.
[9］刘声,张明雪.酒精性肝病研究述略［J］.中医药学刊,2004,22(1):8586.
[10］张九香.浅谈酒精性肝病的中医治疗［J］.湖南中医杂志,2006,22(2):75.
[11］任延明.酒精性肝病的中医病机浅探［J］.青海医学院学报,2004,25(2):140141.
[12］王磊,柳涛,季光,等.清肝活血方对乙醇性肝纤维化大鼠肝星形细胞和肝细胞凋亡的影响［J］.世界华人消化杂志,2006,14(26):25902595.
[13］周滔,刘坚,范江勇,等.解醒冲剂治疗慢性酒精性肝病30例［J］.中西医结合肝脏病杂志,2002,12(3):181182.
[14］丁霞,杨晋翔,王婧,等.酒精性肝纤维化中医证素分析［J］.中国中医基础医学杂志,2009,15(2):136137.
[15］李志红,田德禄,叶永安.洒精性肝纤维化饮洒与中医证候特点分布相关性研究［J］.中国中医药信息杂志,2006,13(2):1315.
[16］李丰衣,田德禄,孙劲晖,等.酒精性肝纤维化中医症状和证候特点的研究［J］.中华中医药学刊,2008,26(11):24092413.
[17］丁霞,刘美颖,李晓林,等.酒精性肝纤维化中医证候学研究［J］.中华中医药杂志,2009,24(10):13581360.
[18］张琴,刘平,陈慧芬,等.肝炎后肝硬化中医证候特点的临床调查研究［J］.中西医结合学报,2003,1(2):108112.
[19］王俊文,王天芳,刘建平,等.肝纤维化中医辨证分型和血清纤维化指标相关性研究的系统评价［J］.中医研究,2011,24(10):1724.
[20］冀爱英,赵英红,杜明瑞.肝炎肝硬化中医证型与免疫学指标的相关性研究［J］.中医药学报,2006,34(3):3940.

相似文献/References:

[1]郑洪光,石燕萍,李秀兰,等.糖尿病合并高血压病中医证候分布调查[J].环球中医药,2012,5(09):684.
[2]李化萍,梁晓春.糖尿病前期人群中医证候特点及干预的研究概况[J].环球中医药,2012,5(10):785.
　LI Hua ping,LIANG Xiao chun..Prediabetes crowd of TCM syndrome characteristics and the general research situation of intervention[J].,2012,5(04):785.
[3]王景,田国庆,梁晓春,等.糖尿病前期患者101例中医证候特点及相关指标分析[J].环球中医药,2012,5(11):808.
　WANG Jing,TIAN Guo qing,LIANG Xiao chun,et al.Analysis on TCM syndrome and related data in 101 cases of prediabetes[J].,2012,5(04):808.
[4]赵铁牛,杨晓南,王惠君,等.基于结构方程模型的中医证候学研究概述[J].环球中医药,2012,5(11):862.
　ZHAO Tie niu,YANG Xiao nan,WANG Hui jun,et al.Summary on the study of traditional Chinese medicine syndrome based on structural equation model[J].,2012,5(04):862.
[5]齐铮,赵进喜,王硕仁,等.糖尿病肾病中医证候分布规律的文献研究[J].环球中医药,2012,5(12):914.
　QI Zheng,ZHAO Jin-xi,WANG Shuo-ren,et al.Distribution regules on syndrone of diabetic nephropathy[J].,2012,5(04):914.
[6]王志斌 韩海啸 余轶群等.幽门螺杆菌根治率与慢性胃炎中医证型的相关性研究[J].环球中医药,2014,7(07):523.
　WANG Zhi-bin,HAN Hai-xiao,YU Yi-qun,et al.Correlation of TCM syndromes and H.pylori eradication rate of chronic gastritis patients[J].,2014,7(04):523.
[7]吴爱明,赵明镜,张冬梅,等.高血压病患者血清白介素6对缺血性中风诊断和辨证的临床意义探讨[J].环球中医药,2015,8(04):399.[doi:10.3969/j.issn.1674-1749.2015.04.004]
　WU Ai-ming,ZHAO Ming-jing,ZHANG Dong-mei,et al.Discussion on the clinical value of serum interleukin- 6 for the diagnosis and syndrome differentiation of ischemic stroke in patients with hypertension[J].,2015,8(04):399.[doi:10.3969/j.issn.1674-1749.2015.04.004]
[8]王文婷 张厂 王林恒 李军祥 胡立明 孟捷 韩海啸 王志斌 陈润花 余轶群 赵薇巍 彭丹.胃食管反流病中医证候学研究探索[J].环球中医药,2016,9(08):931.[doi:10.3969/j.issn.1674-1749.2016.08.007]
　WANG Wen-ting,ZHANG Chang,WANG Lin-heng,et al.Clinical study on the traditional Chinese medicine syndromes of the gastroesophageal reflux disease[J].,2016,9(04):931.[doi:10.3969/j.issn.1674-1749.2016.08.007]
[9]阮越勇,王蓓蕾,李想,等.慢性阻塞性肺疾病稳定期中医证候与理化检测指标的相关性研究[J].环球中医药,2017,10(04):401.[doi:10.3969/j.issn.1674-1749.2017.04.005]
　RUAN Yueyong,WANG Beilei,LI Xiang,et al.Relevant research of TCM syndrome and physical and chemical detection index of stable COPD[J].,2017,10(04):401.[doi:10.3969/j.issn.1674-1749.2017.04.005]
[10]郭晓媛 王暴魁.肾脏病微观辨证的理论探讨[J].环球中医药,2017,10(09):961.[doi:10.3969/j.issn.1674-1749.2017.09.007]
　GUO Xiaoyuan,WANG Baokui..Theoretical discussion of the micro syndrome differentiation of kidney disease[J].,2017,10(04):961.[doi:10.3969/j.issn.1674-1749.2017.09.007]

备注/Memo

备注/Memo:
基金项目：北京中医药大学自主课题项目2010年“益气解毒法对酒精性肝硬化患者肠道屏障功能干预的临床研究”（JYBZZXS080）和2011年“酒精性肝纤维化中医证候的临床及生物学基础研究”（2011JYBZZDS112）
作者单位：100029北京中医药大学第三附属医院消化科[杨晋翔、来要良（博士研究生）]
作者简介：杨晋翔（1958- ），主任医师，教授，博士生导师。研究方向：脾胃肝胆病的临床及实验研究。Email：yjx571102@163.com
更新日期/Last Update: 1900-01-01